Author:
Abdallah A. B.,El-Shafei A. A.,Khalifa Magdi E.
Publisher
Springer Science and Business Media LLC
Reference45 articles.
1. Rafiq, S.M.; Banik, G.R.; Khan, S.; Rashid, H.; Khandaker, G.: Current burden of hepatitis C virus infection among injecting drug users: a mini systematic review of prevalence studies. Infect. Disord. Drug Targets 14, 93–100 (2014)
2. Gentile, I.; Borgia, F.; Buonomo, A.R.; Castaldo, G.; Borgia, G.: A novel promising therapeutic option against hepatitis C virus: an oral nucleotide NS5B polymerase inhibitor sofosbuvir. Curr. Med. Chem. 20, 3733–3742 (2013)
3. Bhatia, H.K.; Singh, H.; Grewal, N.; Natt, N.K.: Sofosbuvir: a novel treatment option for chronic hepatitis C infection. J. Pharmacol. Pharmacother. 4, 278–284 (2014)
4. Shi, X.; Zhu, D.; Lou, J.; Zhu, B.; Hu, A.; Gan, D.: Evaluation of a rapid method for the simultaneous quantification of ribavirin, sofosbuvir and its metabolite in rat plasma by UPLC–MS/MS. J. Chromatogr. B Biomed. Appl. 1002, 353–357 (2015)
5. Pan, C.; Chen, Y.; Chen, W.; Zhou, G.; Jin, L.; Zheng, Y.; Lin, W.; Pan, Z.: Simultaneous determination of ledipasvir, sofosbuvir and its metabolite in rat plasma by UPLC–MS/MS and its application to a pharmacokinetic study. J. Chromatogr. B Biomed. Appl. 1008, 255–259 (2016)
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献